Soi C Law
Overview
Explore the profile of Soi C Law including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
MacManus M, Seymour J, Tsang H, Fisher R, Keane C, Sabdia M, et al.
EBioMedicine
. 2024 Dec;
110:105468.
PMID: 39631145
Background: We report extended follow-up of TROG99.03, a randomised phase III trial in early-stage follicular lymphoma (ESFL) including new information on the role of adjuvant rituximab and translational studies. Methods:...
2.
Gunawardana J, Law S, Sabdia M, Fennell E, Hennessy A, Leahy C, et al.
Am J Hematol
. 2024 Aug;
99(11):2096-2107.
PMID: 39152767
In classical Hodgkin lymphoma (cHL), responsiveness to immune-checkpoint blockade (ICB) is associated with specific tumor microenvironment (TME) and peripheral blood features. The role of ICB in nodular lymphocyte predominant Hodgkin...
3.
Bednarska K, Thillaiyampalam G, Mujaj S, Nourse J, Gunawardana J, Sabdia M, et al.
Acta Haematol
. 2024 Mar;
147(6):676-691.
PMID: 38479365
Introduction: Hodgkin lymphoma (HL) is deficient in major histocompatibility complex class I, rendering it susceptible to antitumoral immunity by natural killer (NK) cells. Despite the functional impairment of PD-1+ NK...
4.
Burgess M, Keane C, Tobin J, Law S, Griffin A, Gill D, et al.
Acta Haematol
. 2022 Oct;
146(2):166-171.
PMID: 36273464
Here, we present a novel case of a patient with chronic lymphocytic leukemia (CLL) who received CTLA-4 and then PD-1 immune-checkpoint blockade (ICB) as treatment for concomitant metastatic melanoma. Whereas...
5.
Law S, Hoang T, ORourke K, Tobin J, Gunawardana J, Loo-Oey D, et al.
Am J Transplant
. 2021 May;
21(10):3465-3471.
PMID: 33942495
Primary central nervous system lymphoma (PCNSL) occurring following organ transplantation (post-transplantation lymphoproliferative disorder [PTLD]) is a highly aggressive non-Hodgkin lymphoma. It is typically treated with high-dose methotrexate-based regimens. Outcomes are...
6.
Keane C, Law S, Gould C, Birch S, Sabdia M, de Long L, et al.
Blood Adv
. 2020 Apr;
4(7):1367-1377.
PMID: 32267932
Blockade of the PD-1 axis has modest efficacy in diffuse large B-cell lymphoma (DLBCL), but data regarding LAG3 are sparse. The impact of LAG3 digital gene expression was tested in...
7.
Cristino A, Nourse J, West R, Sabdia M, Law S, Gunawardana J, et al.
Blood
. 2019 Dec;
134(25):2261-2270.
PMID: 31856276
Epstein-Barr virus-positive (EBV+) diffuse large B-cell lymphomas (DLBCLs) express high levels of programmed death ligand 1 (PD-L1) and PD-L2. MicroRNA (miR) regulation is an important mechanism for the fine-tuning of...